Dr. Karen Earle, MD (she/her) is an Endocrinologist, Internist in San francisco, CA with over 17 years of experience. What is your opinion of Dr. Karen Earle, MD? Rate this provider below so other people can make informed decision.
Over 17 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Karen Earle, MD has received over $252,396 which includes payments from the following companies:
$160,354.42 from sanofi-aventis U.S. LLC
$40,319.82 from Novo Nordisk Inc
$31,128.10 from AstraZeneca Pharmaceuticals LP
$15,067.34 from Dexcom, Inc.
$2,658.91 from INSULET CORPORATION
$584.43 from LILLY USA, LLC
$321.76 from Takeda Pharmaceuticals America, Inc.
$297.51 from Merck Sharp & Dohme Corporation
$251.36 from Abbott Laboratories
$239.15 from Tandem Diabetes Care, Inc.
$213.22 from Janssen Pharmaceuticals, Inc
$120.07 from Amgen Inc.
$106.86 from Alexion Pharmaceuticals, Inc.
$84.83 from Shire North American Group Inc
$76.05 from AbbVie, Inc.
$66.42 from VIVUS, Inc.
$61.93 from Boehringer Ingelheim Pharmaceuticals, Inc.
$52.99 from Regeneron Healthcare Solutions, Inc.
$52.27 from Roche Diagnostics Corporation
$45.48 from Corcept Therapeutics
Payments received by Dr. Karen Earle, MD were from the following categories:
$209,448.25 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!